16 results
8-K
EX-10.1
GLUE
Monte Rosa Therapeutics Inc
26 Oct 23
Monte Rosa Therapeutics Announces $25 Million Registered Direct Offering, Priced At- the-Market Under Nasdaq Rules
5:01pm
of hazardous or toxic substances or relating to the protection or restoration of the environment or human exposure to hazardous or toxic substances
S-3
EX-1.2
GLUE
Monte Rosa Therapeutics Inc
1 Jul 22
Shelf registration
5:01pm
of human health or safety, the environment, natural resources, hazardous or toxic substances or wastes, pollutants or contaminants (collectively … for the investigation or remediation of any disposal or release of hazardous or toxic substances or wastes, pollutants or contaminants, and have no knowledge of any
10-K
2021 FY
EX-10.20
GLUE
Monte Rosa Therapeutics Inc
29 Mar 22
Annual report
4:15pm
to the provisions of Article 27.
21.8. As used herein, the term “Hazardous Material” means any toxic, explosive, corrosive, flammable, infectious, radioactive … pollution conditions including the discharge, dispersal, release or escape of smoke, vapors, soot, fumes, acids, alkalis, toxic chemicals, liquids
10-K
2021 FY
GLUE
Monte Rosa Therapeutics Inc
29 Mar 22
Annual report
4:15pm
of some products for severe or life-threatening diseases, such as cancer, especially when the product may be too inherently toxic to ethically administer … for environmental liability or toxic tort claims that may be asserted against us.
In addition, we may incur substantial costs in order to comply
10-Q
7o7j0olv9
12 Aug 21
Quarterly report
4:22pm
424B4
wmpe dnyz7sx3
25 Jun 21
Prospectus supplement with pricing info
6:08am
S-1/A
jskaih
9 Jun 21
IPO registration (amended)
4:51pm
S-1
j34l2wp9k296xmfyf2a
4 Jun 21
IPO registration
9:07am
S-1
EX-10.19
0hp3ovfyw14cd
4 Jun 21
IPO registration
9:07am
DRS/A
ymcap
21 May 21
Draft registration statement (amended)
12:00am
DRS
EX-10.18
pcddrjmg8wgp8gvvfoxp
19 Apr 21
Draft registration statement
12:00am
DRS
voxj8swsrlihs
19 Apr 21
Draft registration statement
12:00am
- Prev
- 1
- Next